Treatment outcomes of patients with chronic hepatitis C receiving sofosbuvir-based combination therapy within national hepatitis C elimination program in the country of Georgia

BACKGROUND: Georgia has one of the highest HCV prevalence in the world and launched the world’s first national HCV elimination programs in 2015. Georgia set the ambitious target of diagnosing 90% of people living with HCV, treating 95% of those diagnosed and curing 95% of treated patients by 2020. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsertsvadze, Tengiz, Gamkrelidze, Amiran, Nasrullah, Muazzam, Sharvadze, Lali, Morgan, Juliette, Shadaker, Shaun, Gvinjilia, Lia, Butsashvili, Maia, Metreveli, David, Kerashvili, Vakhtang, Ezugbaia, Marina, Chkhartishvili, Nikoloz, Abutidze, Akaki, Kvaratskhelia, Valeri, Averhoff, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954615/
https://www.ncbi.nlm.nih.gov/pubmed/31924172
http://dx.doi.org/10.1186/s12879-019-4741-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954615/
https://www.ncbi.nlm.nih.gov/pubmed/31924172
http://dx.doi.org/10.1186/s12879-019-4741-5

Ejemplares similares